FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s The New York TimesFDA approves a new Alzheimer’s drug from Eli Lilly CNBCFDA approves new Alzheimer’s treatment, donanemab from Eli Lilly CBS NewsApproval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment The Wall Street Journal